Skip to main content

Olimab 60mg injection | Denosumab |Apple pharmaceuticals

Olimab 60mg injection

DESCRIPTION

Olimab 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases.
Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids.
Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides.
Olimab 60mg injection

Olimab 60mg injection


Olimab 60mg injection


PRESCRIBED

Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture.
Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer.
Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer.

DOSAGE

For adult :
Osteoporosis :
Olimab 60mg SC (subcutaneously) once every 6 months
Injection of drug should be done in upper arm, upper thigh or abdomen
Giant Cell Tumor of bone :
120mg SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment
Injection of drug should be done in upper arm, upper thigh or abdomen
Osteolytic Bone Metastases of Solid Tumors :
120mg subcutaneously every 4 weeks
Olimab 60mg injection of drug should be done in upper arm, upper thigh or abdomen
Hypercalcemia :
Dose of 120mg Olimab 60mg injection given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment Injection of drug should be done in upper arm, upper thigh or abdomen
Dosage and administration in pediatric :
13 years and older and 45kg or more
Giant Cell Tumor of bone :
Dose of 120mg Olimab 60mg tablet given SC, every 4 weeks with additional 120mg doses on days 8 and 15 of the 1st month treatment OVERDOSE: Olimab overdose has no overdose. If occurs seek to emergency department and call poison control

MECHANISM

Denosumab linked to RANKL, a protein which is specific for the formation, function and survival of osteoclasts, the cells necessary for bone resorption. Denosumab prohibits osteoclast formation, function and survival hence, reducing bone resorption and raising bone mass and strength of the bone.
Peak plasma concentration: 6.75mcg/mL
Tmax : 10days
Without aggregation in Olimab 60mg pharmacokinetics with duration was noticed upon multiple dosing of 60 mg SC administered once every 6 months.
Pharmacokinetics of Olimab 60mg injection will not affected by the binding antibodies formation.
Half-life is 25.4 days.

PRECAUTION

• Before to start treatment with Olimab 60mg, discuss with the doctor about any other regimens you are using (including over-the-counter drugs, vitamins, or herbal remedies). Do not take aspirin or products containing aspirin unless your doctor permits this.
• Olimab 60mg injection may improve the negative effects of immuno-suppressants. Especially the risk for serious infections may be increased. Inform your doctor of any immuno-suppressive drugs you early consume.
• Not to receive any type of vaccination without your doctor's consultation while admonishing Denosumab.
• Use in pregnancy only if benefit to mother outweighs risk to fetus. Consult with doctor before the treatment
• During Olimab 60mg treatment do not breastfeed your infants.

DRUG INTERACTION

No formal drug-drug interaction with Denosumab during trials.
When interacting with some anticancer drug, orthopedic drugs, vaccines will lead to risk of adverse effects can be increased

CONTRAINDICATION

Olimab 60mg  is contraindicated in patients having Hypocalcemia, Pregnancy, Hypersensitivity

STORAGE

Store at 2℃ to 8℃ in the original container, avoid freeze
Before to administration keep at room temperature
Olimab 60mg injection protect from direct light and heat.

SIDE EFFECTS

Common side effects for the patient taking Olimab 60mg as follows :
Fatigue, Muscle weakness, Phosphorus level reduced in blood, Nausea
Less common side effects for patients taking Olimab 60mg
Dyspnea, Hypocalcemia, Cough, Arthralgia, Limb pain, Eczema, Headache

MISSED DOSE

Take the dose immediately before next dose duration, then left off the missed dose and continue regular schedule. Avoid taking double dose at same time.
Please consult the doctor for further information.

Address:

Apartment No.304 A Wing,

Shiva Sakthi chs lts,

JP Road, Near Apna Bazar,

Andheri(West),

Mumbai - 400058

Maharashtra.

Ph number:

+91-9987711567

Mail id:

applepharamaceutical@gmail.com
Labels:

Comments

Post a Comment

Popular posts from this blog

Rozel 60mg injection dose, tablet | Apple pharmaceuticals

Rozel 60mg injection DESCRIPTION Rozel 60mg belongs to novel, fully human IgG2 monoclonal antibody especially to receptor activator of nuclear factor kappa-B ligand (RANKL), restrain bone resorption markers in patients with a difference of metastatic tumors and is being examined in multiple clinical trials for the inhibition and treatment of bone metastases. Chemically, it exists of 2 heavy and 2 light chains. Each light chain contains of 215 amino acids. Each heavy chain contains of 448 amino acids with 4 intramolecular disulfides. Rozel 60mg injection PRESCRIBED FOR Treatment for patients having postmenopausal women with osteoporosis at high risk for fracture. Treatment for patients with increase bone mass in men at more risk for fracture getting androgen deprivation therapy for non-metastatic prostate cancer. Treatment for patients having to increase bone mass in women at more risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. DOSAGE Fo...
Post a Comment
Read more

Glenza 40 mg capsules (Enzalutamide ) Uses & Side effects|Apple pharmaceuticals

Glenza 40 mg capsules DESCRIPTION Glenza 40mg is a hormonal therapy, for men who are all affected with prostate carcinoma in metastaic stage. Glenza 40mg Capsules are majorly indicated for prostate carcinoma, which contains Enzalutamide, as an active component considered as non steroidal anti-androgen medication. Glenza 40mg capsule is involved in association with castration in the therapy of metastatic or long lasting castration resistant prostate cancer. Glenza 40mg is a prescription medicine, the main ingredient which is used as Enzalutamide , only prescribed by medical oncologist. Glenza 40mg Capsule CAPSULES INDICATIONS The primary usage of Glenza 40mg Capsule is involved in the effective treatment of mCRPC (metastatic castration resistant prostate cancer), taken orally. The effect of anti-androgen viewing by obstruct the testosterone production by inhibiting androgen synthesis, the hormone which is require for cancer cell growth. Glenza 40mg is majorly used to ...
Post a Comment
Read more

Azel Dr Reddy's Enzalutamide 40 mg capsules|Uses & Side effects

Azel Dr Reddy's Enzalutamide 40 mg capsules DESCRIPTION Azel 40mg is a hormonal therapy, for men who are all affected with prostate carcinoma in metastaic stage. Azel40mg Capsules are majorly indicated for prostate carcinoma, which contains Enzalutamide , as an active component considered as non steroidal anti-androgen medication. Azel 40mg is involved in association with castration in the therapy of metastatic or long lasting castration resistant prostate cancer. Azel 40mg is a prescription medicine, the main ingredient which is used as Enzalutamide , only prescribed by medical oncologist. Azel 40mg capsule CAPSULES INDICATIONS The primary usage of Azel 40mg Capsule is involved in the effective treatment of mCRPC (metastatic castration resistant prostate cancer), taken orally. The effect of anti-androgen viewing by obstruct the testosterone production by inhibiting androgen synthesis, the hormone which is require for cancer cell growth. Azel 40mg is majorly u...
Post a Comment
Read more